financetom
Business
financetom
/
Business
/
Stellantis US-Listed Shares Tumble as CEO Quits
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis US-Listed Shares Tumble as CEO Quits
Dec 2, 2024 10:12 AM

12:54 PM EST, 12/02/2024 (MT Newswires) -- US-listed shares of Stellantis ( STLA ) slid intraday Monday after the automaker said Sunday that Chief Executive Carlos Tavares resigned more than a year before his contract was set to expire.

The manufacturer of Chrysler, Fiat and Jeep plans to establish an interim committee until a permanent replacement for Tavares is named, currently expected in the first half of 2025. The committee will be headed by board Chairman John Elkann.

"Stellantis' ( STLA ) success since its creation has been rooted in a perfect alignment between the reference shareholders, the board and the CEO," Senior Independent Director Henri de Castries said in Sunday's statement. "However, in recent weeks different views have emerged, which have resulted in the board and the CEO coming to today's decision."

Stellantis' ( STLA ) New York Stock Exchange-listed shares declined 6.6% in midday trade.

In October, Stellantis ( STLA ) indicated that Tavares planned to retire at the end of his CEO contract in early 2026 and that a process to identify his replacement was already under way.

Stellantis ( STLA ) on Sunday affirmed the lowered full-year guidance it issued at the end of September. It said at the time that the revised outlook reflected deteriorating global industry dynamics amid increasing competition and decisions to "significantly enlarge remediation actions on North American performance issues."

The automaker said in September that it expected adjusted operating income margin to range between 5.5% and 7% in 2024, down from an earlier projection of a double-digit figure. It continues to expect negative industrial free cash flow.

Third-quarter revenue slid 27% year over year, in part reflecting lower shipments, Stellantis ( STLA ) said at the end of October. Consolidated shipments fell 20% from the same period of 2023 to 1.15 million units.

Price: 12.33, Change: -0.88, Percent Change: -6.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BP and Total deepen commitments to US with major projects
BP and Total deepen commitments to US with major projects
Sep 29, 2025
HOUSTON/LONDON (Reuters) -European oil and gas majors BP and TotalEnergies on Monday deepened their commitments to the United States, with BP approving a $5 billion offshore oil field and TotalEnergies buying into an onshore gas field. Higher investment in U.S. oil and gas production aligns with U.S. President Donald Trump's goal to capitalise on the country's hydrocarbon resources. BP, which...
AstraZeneca Moves From ADRs To NYSE Listing
AstraZeneca Moves From ADRs To NYSE Listing
Sep 29, 2025
The Board of AstraZeneca plc ( AZN ) is recommending to shareholders a Harmonized Listing Structure for the company's ordinary shares across the London Stock Exchange (LSE), Nasdaq Stockholm (STO), and the New York Stock Exchange (NYSE). It requires upgrading AstraZeneca's ( AZN ) existing U.S. equity listing by way of a direct listing of AstraZeneca ( AZN ) ordinary...
Western Midstream, Aris Water Say Key Condition for Merger has Been Met
Western Midstream, Aris Water Say Key Condition for Merger has Been Met
Sep 29, 2025
08:27 AM EDT, 09/29/2025 (MT Newswires) -- Western Midstream Partners ( WES ) and Aris Water Solutions ( ARIS ) said Monday that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired, which was a key condition for their merger to close. In August, Western Midstream ( WES ) had signed a definitive agreement to acquire...
Novartis Unit Begins Tender Offer to Acquire Tourmaline Bio
Novartis Unit Begins Tender Offer to Acquire Tourmaline Bio
Sep 29, 2025
08:26 AM EDT, 09/29/2025 (MT Newswires) -- Novartis ( NVS ) said Monday its Torino indirect subsidiary has commenced a tender offer to purchase all outstanding shares of Tourmaline Bio ( TRML ) for $48 per share in cash. The tender offer will expire on Oct. 27 unless extended, the company said. Earlier in September, Tourmaline Bio ( TRML )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved